BioStem Technologies Announces Nasdaq Listing (Ticker: BSEM)

What Happened

• BioStem Technologies, Inc. (BSEM) announced on August 6, 2026 that The Nasdaq Stock Market LLC approved its common stock for listing on The Nasdaq Capital Market. Trading transitioned from the OTCID Basic Market to Nasdaq effective at the opening of trading on August 7, 2026, and the shares now trade under the existing ticker symbol "BSEM."
• The company filed the announcement as an Item 8.01 Other Events in an 8-K dated August 7, 2026; the filing includes a press release (Exhibit 99.1) and is signed by CEO Jason Matuszewski.

Key Details

• Nasdaq approval announced: August 6, 2026.
• Effective trading transition: opening of trading on August 7, 2026.
• New trading venue: The Nasdaq Capital Market (from OTCID Basic Market).
• Ticker symbol: BSEM; shareholders are not required to take any action per the filing.

Why It Matters

• The filing confirms a formal market venue change: investors should note that BSEM shares now trade on Nasdaq rather than the OTCID Basic Market. This is an administrative change recorded in the company’s SEC report and may affect how investors find and trade the stock. For more details, see the company’s press release filed as Exhibit 99.1.